32
BioImpact Equities Fund, LP updates its Form D — $109.5M sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $109.5M · BOSTON, MA · filed 2025-03-10
32
BioImpact Equities Fund, LP updates its Form D — $125.5M sold
Fund raise update · Hedge fund · Open-ended · BOSTON, MA · Form D/A filed 2026-03-10 · all Bioimpact Equities vehicles
$100M+ sold
Why now — by persona
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
People on the filing
| Christiana Goh Bardon | Dr. Bardon is the Managing Member of the General Partner of the Issuer and the Co-Managing Partner of BioImpact Capital LLC, the Investment Manager of the Issuer. |
| Kristen Goh Laguerre | Ms. Laguerre is the Partner, Finance and Operations Director and Authorized Signatory of the General Partner of the Issuer |
| Christopher Goh Wolf | Mr. Wolf is the Chief Financial Officer and Authorized Signatory of the General Partner of the Issuer |
| n/a BioImpact Equities LLC | The General Partner of the Issuer. |
Signed by Christopher Wolf, Authorized Signatory of the General Partner of the Issuer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.